Cargando…

Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis

PURPOSE: The aim of this review was to compare radiation toxicity in Localized Prostate Cancer (LPC) patients who underwent conventional fractionation (CV), hypofractionated (HYPO) or extreme hypofractionated (eHYPO) radiotherapy. We analyzed the impact of technological innovation on the management...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Franco, Rossella, Borzillo, Valentina, Ravo, Vincenzo, Ametrano, Gianluca, Falivene, Sara, Cammarota, Fabrizio, Rossetti, Sabrina, Romano, Francesco Jacopo, D’Aniello, Carmine, Cavaliere, Carla, Iovane, Gelsomina, Piscitelli, Raffaele, Berretta, Massimiliano, Muto, Paolo, Facchini, Gaetano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370048/ https://www.ncbi.nlm.nih.gov/pubmed/28129649 http://dx.doi.org/10.18632/oncotarget.14798

Ejemplares similares

Exploring the molecular aspects associated with testicular germ cell tumors: a review
por: Facchini, Gaetano, et al.
Publicado: (2017)

Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

Epithelial-mesenchymal transition in prostate cancer: an overview
por: Montanari, Micaela, et al.
Publicado: (2017)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
por: Rossetti, Sabrina, et al.
Publicado: (2017)

Testicular cancer from diagnosis to epigenetic factors
por: Boccellino, Mariarosaria, et al.
Publicado: (2017)

Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer
por: Serra, Marcello, et al.
Publicado: (2020)

Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences
por: Quagliariello, Vincenzo, et al.
Publicado: (2017)

Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences
por: Quagliariello, Vincenzo, et al.
Publicado: (2017)

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
por: D'Aniello, Carmine, et al.
Publicado: (2019)

From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples
por: Facchini, Gaetano, et al.
Publicado: (2016)

ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review
por: Botti, Gerardo, et al.
Publicado: (2017)

Micrornas in prostate cancer: an overview
por: Vanacore, Daniela, et al.
Publicado: (2017)

Detection of a numeric value predictive of increased dose to left anterior descending coronary artery (LAD) in radiotherapy of breast cancer
por: Di Franco, R., et al.
Publicado: (2016)

Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
por: Facchini, Gaetano, et al.
Publicado: (2016)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014)

Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review
por: Romano, Francesco Jacopo, et al.
Publicado: (2016)

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
por: Perri, Francesco, et al.
Publicado: (2015)

Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife(®) System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity(®): Outcomes, Toxicities and Dosimetric Evaluation
por: Di Franco, Rossella, et al.
Publicado: (2022)

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study
por: D'Aniello, Carmine, et al.
Publicado: (2016)

Stereotactic body radiotherapy with CyberKnife(®) System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial
por: Borzillo, Valentina, et al.
Publicado: (2023)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study
por: Serra, Marcello, et al.
Publicado: (2022)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
por: Borzillo, Valentina, et al.
Publicado: (2021)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results
por: Facchini, Gaetano, et al.
Publicado: (2019)

Coffee Decreases the Risk of Endometrial Cancer: A Dose–Response Meta-Analysis of Prospective Cohort Studies
por: Lafranconi, Alessandra, et al.
Publicado: (2017)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
por: Valeriani, Maurizio, et al.
Publicado: (2022)

Radiotherapy in the Treatment of Subcutaneous Melanoma
por: Borzillo, Valentina, et al.
Publicado: (2021)

Preventing the acute skin side effects in patients treated with radiotherapy for breast cancer: the use of corneometry in order to evaluate the protective effect of moisturizing creams
por: Di Franco, Rossella, et al.
Publicado: (2013)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
por: Lo Greco, Maria Chiara, et al.
Publicado: (2023)

Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)
por: Del Pup, Lino, et al.
Publicado: (2016)

Refinement & validation of rectal wall dose volume objectives for prostate hypofractionation in 20 fractions
por: Sanguineti, Giuseppe, et al.
Publicado: (2020)

Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial
por: Passardi, Alessandro, et al.
Publicado: (2020)

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
por: Berretta, Massimiliano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ochgp9ocicrk79k9o8s0p0fajc